Diametric Capital, LP Nevro Corp Transaction History

Diametric Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$44.22 - $75.47 $250,904 - $428,216	-5,674 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$72.38 - $92.5 $44,007 - $56,240	-608 Reduced 9.68%	5,674 $453,000
Q1 2018 May 15, 2018	SELL	$69.46 - $88.57 $58,485 - $74,575	-842 Reduced 11.82%	6,282 $544,000
Q4 2017 Feb 14, 2018	BUY	$65.94 - $93.31 $469,756 - $664,740	7,124	7,124 $492,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Diametric Capital, LP with notifications on news.